| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 86.83B | 84.46B | 83.63B | 76.54B | 75.58B |
| Gross Profit | 50.94B | 41.76B | 48.94B | 43.62B | 43.51B |
| EBITDA | 52.92B | 51.90B | 51.74B | 46.77B | 46.43B |
| Net Income | 32.09B | 30.65B | 30.70B | 25.88B | 25.45B |
Balance Sheet | |||||
| Total Assets | 1.18T | 1.18T | 1.19T | 1.19T | 1.19T |
| Cash, Cash Equivalents and Short-Term Investments | 37.63B | 32.47B | 51.03B | 44.89B | 63.11B |
| Total Debt | 522.23B | 521.30B | 519.38B | 517.47B | 517.80B |
| Total Liabilities | 578.13B | 576.97B | 577.44B | 572.45B | 572.61B |
| Stockholders Equity | 603.15B | 606.20B | 614.69B | 615.13B | 619.90B |
Cash Flow | |||||
| Free Cash Flow | 43.27B | 35.67B | 37.08B | 16.68B | 19.37B |
| Operating Cash Flow | 79.03B | 75.74B | 65.19B | 50.64B | 43.32B |
| Investing Cash Flow | -39.25B | -41.86B | -31.76B | -37.73B | -23.95B |
| Financing Cash Flow | -34.26B | -39.25B | -27.28B | -31.13B | -31.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥665.26B | 10.14 | 5.51% | 4.64% | 24.10% | -30.38% | |
71 Outperform | ¥751.78B | 11.62 | 5.22% | 4.21% | 2.76% | 6.04% | |
69 Neutral | ¥878.16B | 24.15 | 6.59% | 3.83% | -1.97% | -2.16% | |
66 Neutral | ¥1.20T | 16.01 | 5.94% | 3.40% | -7.30% | 7.83% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥731.53B | 25.28 | ― | 4.10% | 12.04% | 12.83% | |
57 Neutral | ¥840.12B | 19.71 | 6.39% | 4.62% | 40.15% | 27.43% |